CytomX Therapeutics, Inc.

MetLife Investment Management, LLC CTMX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

Shares

104,635

Value ($000)

392

Weight

0.0%

2018 Q3 - 2026 Q2 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	392	0.0%	104,635	6/30/2026
2022 Q1	5/10/2024	47	0.0%	17,692	3/31/2022
2021 Q4	5/17/2024	106	0.0%	24,446	12/31/2021
2021 Q3	5/17/2024	50	0.0%	9,880	9/30/2021
2021 Q2	5/17/2024	165	0.0%	26,108	6/30/2021
2021 Q1	5/17/2024	41	0.0%	5,262	3/31/2021
2020 Q4	5/24/2024	98	0.0%	15,026	12/31/2020
2020 Q3	5/24/2024	100	0.0%	15,026	9/30/2020
2020 Q2	5/24/2024	227	0.0%	27,302	6/30/2020
2020 Q1	7/12/2023	209	0.0%	27,302	3/31/2020
2019 Q4	7/12/2023	227	0.0%	27,302	12/31/2019
2019 Q3	7/12/2023	201	0.0%	27,302	9/30/2019
2019 Q2	7/12/2023	306	0.0%	27,302	6/30/2019
2019 Q1	7/13/2023	197	0.0%	18,290	3/31/2019
2018 Q4	7/13/2023	276	0.0%	18,290	12/31/2018
2018 Q3	7/13/2023	338	0.0%	18,290	9/30/2018